Cargando…

Ciprofloxacin-Resistant Pseudomonas aeruginosa Lung Abscess Complicating COVID-19 Treated with the Novel Oral Fluoroquinolone Delafloxacin

PURPOSE: We report the development of a lung abscess caused by a ciprofloxacin-resistant Pseudomonas aeruginosa in a patient with COVID-19 on long-term corticosteroid therapy. Successful antimicrobial treatment included the novel oral fluoroquinolone delafloxacin suggesting an oral administration op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panholzer, Jürgen, Neuboeck, Matthias, Shao, Guangyu, Heldt, Sven, Winkler, Markus, Greiner, Paul, Fritsch, Norbert, Lamprecht, Bernd, Salzer, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866028/ https://www.ncbi.nlm.nih.gov/pubmed/35223121 http://dx.doi.org/10.1155/2022/1008330

Ejemplares similares

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Cystic Fibrosis Sputum Model
por: Craddock, Vaughn D., et al.
Publicado: (2023)

Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
por: Tulkens, Paul M, et al.
Publicado: (2019)

Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021)

Human Target Attainment Probabilities for Delafloxacin against Escherichia coli and Pseudomonas aeruginosa
por: Hoover, Randall, et al.
Publicado: (2017)

Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use
por: MacDougall, Conan, et al.
Publicado: (2005)

Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa
por: Zhao, Lei, et al.
Publicado: (2020)

Rare manifestation of a large stenosing gastrointestinal tumor caused by Mycobacterium tuberculosis in a previously healthy man from Austria
por: Shao, Guangyu, et al.
Publicado: (2021)

Emerging COVID-19 reinfection four months after primary SARS-CoV-2 infection
por: Salzer, Helmut J. F., et al.
Publicado: (2021)

qSOFA score poorly predicts critical progression in COVID-19 patients
por: Heldt, Sven, et al.
Publicado: (2021)

Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin
por: Kolpen, Mette, et al.
Publicado: (2017)

Activity of Antimicrobial Peptides and Ciprofloxacin against Pseudomonas aeruginosa Biofilms
por: Yasir, Muhammad, et al.
Publicado: (2020)

Thermal Shock and Ciprofloxacin Act Orthogonally on Pseudomonas aeruginosa Biofilms
por: Aljaafari, Haydar, et al.
Publicado: (2021)

Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
por: Usman, Muhammad, et al.
Publicado: (2023)

Plasmid-Mediated Fluoroquinolone Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii
por: Venkataramana, Geetha P., et al.
Publicado: (2022)

Resistance development in Escherichia coli to delafloxacin at pHs 6.0 and 7.3 compared to ciprofloxacin
por: Bösch, Anja, et al.
Publicado: (2023)

Delafloxacin-Capped Gold Nanoparticles (DFX-AuNPs): An Effective Antibacterial Nano-Formulation of Fluoroquinolone Antibiotic
por: Abu Lila, Amr Selim, et al.
Publicado: (2022)

Mechanisms for Development of Ciprofloxacin Resistance in a Clinical Isolate of Pseudomonas aeruginosa
por: Xu, Congjuan, et al.
Publicado: (2021)

Synergy between Indoloquinolines and Ciprofloxacin: An Antibiofilm Strategy against Pseudomonas aeruginosa
por: Charpentier, Emilie, et al.
Publicado: (2021)

Enhanced Biosynthesis of Fatty Acids Contributes to Ciprofloxacin Resistance in Pseudomonas aeruginosa
por: Su, Yu-bin, et al.
Publicado: (2022)

Potential Synergistic Antibiotic Combinations against Fluoroquinolone-Resistant Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2022)

Antimicrobial Pressure of Ciprofloxacin and Gentamicin on Biofilm Development by an Endoscope-Isolated Pseudomonas aeruginosa
por: Machado, Idalina, et al.
Publicado: (2012)

Ciprofloxacin binding to GyrA causes global changes in the proteome of Pseudomonas aeruginosa
por: Jedrey, Hannah, et al.
Publicado: (2018)

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
por: Feng, Xinyuan, et al.
Publicado: (2019)

Pseudomonas aeruginosa Polynucleotide Phosphorylase Contributes to Ciprofloxacin Resistance by Regulating PrtR
por: Fan, Zheng, et al.
Publicado: (2019)

ICEs Are the Main Reservoirs of the Ciprofloxacin-Modifying crpP Gene in Pseudomonas aeruginosa
por: Botelho, João, et al.
Publicado: (2020)

Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa
por: Cho, Hye Hyun, et al.
Publicado: (2014)

Detection of Overexpression of Efflux Pump Expression in Fluoroquinolone-Resistant Pseudomonas aeruginosa Isolates
por: Al Rashed, Nouf, et al.
Publicado: (2020)

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina
por: Boni, Silvia, et al.
Publicado: (2022)

DELAFLOXACIN, A NOVEL FLUOROQUINOLONE ANTIBIOTIC WITH ACTIVITY AGAINST HOSPITAL-, COMMUNITY- AND LIVESTOCK- ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
por: Maguire, Mollie, et al.
Publicado: (2021)

2754. Delafloxacin and Comparator Fluoroquinolone In Vitro Resistance Trends in Isolates from Skin and Skin Structure Infections in the USA (2017–2022)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2023)

Delafloxacin: First Global Approval
por: Markham, Anthony
Publicado: (2017)

Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis
por: Carion, Thomas W, et al.
Publicado: (2018)

Understanding Ciprofloxacin Failure in Pseudomonas aeruginosa Biofilm: Persister Cells Survive Matrix Disruption
por: Soares, Anaïs, et al.
Publicado: (2019)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of Pseudomonas aeruginosa Phages
por: Danis-Wlodarczyk, Katarzyna M., et al.
Publicado: (2021)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017)

Intra-ocular Predation of Fluoroquinolone-Resistant Pseudomonas aeruginosa and Serratia marcescens by Predatory Bacteria
por: Romanowski, Eric G., et al.
Publicado: (2023)

Methylprednisolone: Pseudomonas aeruginosa lung abscess: case report
Publicado: (2022)

2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
por: Sansom, Sarah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u538vnh0gcmv0c68kif6ehe0s4